Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
申请人:Ohhata Akira
公开号:US20050222138A1
公开(公告)日:2005-10-06
A nitrogen-containing bicyclic compound of formula (I) or a pharmaceutically acceptable salt thereof (wherein the symbols have the same meanings as described in the specification).
The compound of formula (I) has an inhibitory activity against PDE7 and it is useful for the prevention and/or treatment of various diseases, i.e. autoimmune diseases (ulcerative colitis, Crohn's disease, rheumatism, psoriasis, multiple sclerosis, collagenosis, etc.), inflammatory diseases (obstructive pulmonary disease, sepsis, pancreatitis, sarcoidosis, nephritis, hepatitis, enteritis, etc.), allergic diseases (asthma, allergic rhinitis, allergic conjunctivitis, seasonal conjunctivitis, atopic dermatitis, etc.), rejection of organ transplants, serious graft versus host disease (GVHD), diabetic disease, osteoporosis, bone fracture, restenosis, atherosclerosis, obesity, ischemic reperfusion injury, depression, Parkinson's disease, dementia, leukemia, etc.
化学式(I)的含氮双环化合物或其药用盐(其中符号的含义与说明书中描述的相同)。
化合物的化学式(I)具有对PDE7的抑制活性,对于预防和/或治疗各种疾病非常有用,即自身免疫性疾病(溃疡性结肠炎、克罗恩病、风湿病、牛皮癣、多发性硬化症、结缔组织病等)、炎症性疾病(慢性阻塞性肺病、败血症、胰腺炎、结节病、肾炎、肝炎、肠炎等)、过敏性疾病(哮喘、过敏性鼻炎、过敏性结膜炎、季节性结膜炎、特应性皮炎等)、器官移植排斥、严重移植物抗宿主病(GVHD)、糖尿病、骨质疏松症、骨折、再狭窄、动脉粥样硬化、肥胖症、缺血再灌注损伤、抑郁症、帕金森病、痴呆症、白血病等。